Tirzepatide (Mounjaro and Zepbound) - Tirzepatide is a dual-action therapy that targets GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors for enhanced weight loss benefits
As a result, patients often feel more capable of completing workouts and staying active throughout the day
These limitations require careful consideration when selecting supplementation strategies for specific health goals
Schedule a virtual visit through the Nice app to get startedand take the first step toward feeling your best today.
Long-term success is supported by a structured plan: nutrition, physical activity, behavior therapy, monitoring, and follow-ups
If someone becomes pregnant while taking a GLP-1, the key is not to panic, but to stop the medication and talk with a clinician about the safest path forward for both parent and baby